Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation
Molecular Oncology · 2025
DOI: 10.1002/1878-0261.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Ignacio J Cardona-Benavides und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Spain. Hauptthemen laut MEDLINE: Multiple Myeloma, Cyclin D1, Cell Cycle Checkpoints. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Junta de Castilla y León, Fundación Científica Asociación Española Contra el Cáncer, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Cyclins D could be a unifying event in multiple myeloma (MM), even though MM is not typically considered a proliferative disease. In this study, we hypothesized that cyclins D might have additional roles in the pathogenesis of MM beyond cell cycle control. We showed that overexpression of CCND1 and CCND2 in MM cell lines lacking these proteins revealed a mutually exclusive expression pattern, with both cyclins D localized in the cytoplasm and no impact on proliferation. To investigate non‐canonical roles of cyclin D1, we performed transcriptome analysis and multidimensional flow cytometry. Cyclin D1 overexpression led to upregulation of several key cell adhesion pathway proteins, including STAT1 and ZO‐1, along with alterations in the actin cytoskeleton and decreased adhesion to certain matrices. Immunophenotypic analysis showed a significant reduction in CD56 expression following cyclin D1 overexpression, validated in a cohort of 85 MM patients, in which 73% with high cyclin D1 were CD56‐negative. High cyclin D1 was also associated with increased circulating tumor cells (CTCs) ( P < 0.001). Overall, we revealed novel functions of cyclin D1 in MM pathogenesis, particularly in cell adhesion and dissemination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology Department, Institute of Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Spain.
- Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain.
- Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
- Clínica Universidad de Navarra, Centro de Investigaciones Biomédicas Aplicadas (CIMA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
ORCID-Profile: Ignacio J Cardona-Benavides
Förderung
- Junta de Castilla y León
- Fundación Científica Asociación Española Contra el Cáncer
- Instituto de Salud Carlos III
Zitieren
APA
Cardona-Benavides, I. J., Cristobal-Vargas, S., De Ramón, C., Rojas, E. A., Misiewicz-Krzeminska, I., Isidro, I., Pérez, J. J., Paiva, B., Puig, N., Alcoceba, M., Mateos, M. V., Corchete, L. A., Cuadrado, M., & Gutiérrez, N. C. (2025). Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation. Molecular Oncology. https://doi.org/10.1002/1878-0261.70085
Vancouver
Cardona-Benavides IJ, Cristobal-Vargas S, De Ramón C, Rojas EA, Misiewicz-Krzeminska I, Isidro I, et al. Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation. Molecular Oncology. 2025. doi:10.1002/1878-0261.70085
BibTeX
@article{CardonaBenavides2025,
author = {Cardona-Benavides, Ignacio J and Cristobal-Vargas, Sara and De Ramón, Cristina and Rojas, Elizabeta A and Misiewicz-Krzeminska, Irena and Isidro, Isabel and Pérez, José Juan and Paiva, Bruno and Puig, Noemi and Alcoceba, Miguel and Mateos, María-Victoria and Corchete, Luis A and Cuadrado, Myriam and Gutiérrez, Norma C},
title = {Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation},
journal = {Molecular Oncology},
year = {2025},
doi = {10.1002/1878-0261.70085}
}
EUVIMED